Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
about
Visual dysfunction in Parkinson's diseaseMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineRetinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and BeyondThe avascular zone and neuronal remodeling of the fovea in Parkinson disease.A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.Progressive retinal structure abnormalities in multiple system atrophy.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.Neuropathobiology of non-motor symptoms in Parkinson disease.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Neuropathological basis of nonmotor manifestations of Parkinson's disease.The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis.The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.Self-perception and determinants of color vision in Parkinson's disease.Patterns of Tau and α-Synuclein Pathology in the Visual System.Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.Retinal thinning correlates with clinical severity in multiple system atrophy.Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy.Melanopsin-mediated pupil function is impaired in Parkinson's disease.Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease.Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease
P2860
Q26740467-344CF9C7-FA52-4730-B87B-2A13FE905DF4Q26768648-7D60FE5E-B595-4A59-986E-43B61EABE586Q33634088-A1307DC4-1E93-4913-A823-4D3B8CCE0035Q35115924-5A244290-3E9F-431F-9F16-7D93551A7651Q35764753-6BE3F703-DBAD-48F8-851E-6D1A2DD48C38Q36040485-65ACEE08-B5C2-4944-B81B-0668E1741BABQ36057067-238DADC5-923A-456C-9625-D506B3FF1D66Q36121377-A63307FE-571F-4C21-BE91-792DC689CF2EQ37020745-BF36E265-EBDA-4B2B-83E8-4D31D7871967Q38481481-FD65ADC6-6753-46FE-9C7E-FA31B189695FQ38669105-0245ADF6-E52D-4013-9DED-DD54D7807AE9Q38794098-56E1B16E-7787-49D0-BE7C-A817D2939167Q39360892-93215506-A99A-4690-A809-0A7CEF260A72Q39449147-6896C802-E97C-49CE-A146-79BA7AD41CC8Q40623674-F6BA80BB-BCAD-406F-9370-35AC9EB7A13FQ42095746-06148FDF-4B06-42D6-A397-B41759B20298Q47216019-8FF41FE5-DF1A-410B-8450-607850E16651Q48298552-F9C8447F-D03C-4AFE-992B-7864B8A5D104Q48370104-59C0E583-0139-4A61-9797-83D08AF3AACDQ49761625-522E0A09-3D3B-47FC-8E89-5F9EE3D236E2Q50609715-F8B493D3-BB8A-4364-B3A4-9B563AB6793AQ53301649-BE238818-77D0-4C97-AF74-FFEB205B48C4Q54984688-B2B7F425-8EF1-40B4-9757-13211EEA06F7Q55262235-3BB0283C-5372-4817-957A-796C9EFA5F65Q58756720-919D87C6-E142-4880-A753-4B638EE9F247
P2860
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@ast
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@en
type
label
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@ast
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@en
prefLabel
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@ast
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@en
P2093
P2860
P921
P1433
P1476
Phosphorylated α-synuclein-imm ...... Parkinson's disease subjects.
@en
P2093
Arizona Parkinson's Disease Consortium
Geidy Serrano
Haruhiko Akiyama
Holly A Shill
Jeremiah Carew
Lucia I Sue
Marwan N Sabbagh
Nicolás Cuenca
P2860
P356
10.1016/J.NEULET.2014.04.027
P407
P577
2014-04-28T00:00:00Z